Close Menu

NEW YORK (GenomeWeb) – Pangea Laboratory said yesterday that it has licensed a urine-based laboratory-developed test for bladder cancer detection from Zymo Research.

Commercialized and sold under the name Bladder Care, the test uses qPCR to measure the methylation level of three bladder cancer-specific biomarkers in patient urine samples that can be collected at home or in a physician's office.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers in India plan to sequence SARS-CoV-2 isolates from around the country, according to LiveMint.

Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.

Stat News reports some health tech startups are laying off or furloughing workers.

In Genome Research this week: indels affecting microsatellites in cancer, analytical approach to find key regulatory elements, and more.